ImmunityBio, Inc. Common Stock (IBRX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for IBRX. 13F holdings as of 2026-09-30.
In 13F filings for the quarter ended September 30, 2026, 320 institutions reported holding IBRX, with 158.4 million shares worth $1.5 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Vanguard | 41,734,134 | $394M | INCREASED |
| BlackRock | 36,123,813 | $341M | INCREASED |
| State Street | 21,095,418 | $199M | DECREASED |
| Geode Capital Management | 10,606,654 | $100M | INCREASED |
| UBS Group | 3,775,302 | $36M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Barry J. Simon (Director) | SELL | 25,000 | $269K | 2026-10-05 |
| Cheryl Cohen (Director) | EXERCISE | 55,979 | $167K | 2026-10-02 |
| Cheryl Cohen (Director) | SELL | 81,056 | $851K | 2026-10-02 |
| Cheryl Cohen (Director) | EXERCISE | 55,979 | $167K | 2026-10-02 |
Recent Congressional Trades
| Member | Type | Amount | Date |
|---|---|---|---|
| Lisa C. McClain (Republican) | PURCHASE | $1,001 - $15,000 | 2026-09-30 |
| Lisa C. McClain (Republican) | PURCHASE | $1,001 - $15,000 | 2026-09-28 |
Full institutional holdings, insider history, and congressional trades for ImmunityBio, Inc. Common Stock on SentiSense.